These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30949839)

  • 1. Which treatment is best for patients with AJCC stage IV bladder cancer?
    Mao W; Ma B; Huang X; Gu S; Luo M; Fan J; Geng J
    Int Urol Nephrol; 2019 Jul; 51(7):1145-1156. PubMed ID: 30949839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer.
    Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG
    Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.
    D'Andrea D; Soria F; Zehetmayer S; Stangl-Kremser J; Grubmüller B; Abufaraj M; Gust K; Kimura S; Babjuk M; Goldner GM; Shariat SF
    Scand J Urol; 2020 Feb; 54(1):52-57. PubMed ID: 31975654
    [No Abstract]   [Full Text] [Related]  

  • 10. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.
    Di Trapani E; Sanchez-Salas R; Gandaglia G; Rocchini L; Moschini M; Lizee D; Carneiro A; Sivaraman A; Barret E; Rozet F; Galiano M; Bennamoun M; Colombo R; Suardi N; Briganti A; Montorsi F; Cathelineau X
    World J Urol; 2016 Feb; 34(2):207-13. PubMed ID: 26198750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
    Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
    J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
    BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
    Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
    Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
    Lane G; Risk M; Fan Y; Krishna S; Konety B
    BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
    Abdollah F; Sun M; Jeldres C; Schmitges J; Thuret R; Djahangirian O; Tian Z; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2012 Feb; 109(4):564-9. PubMed ID: 21810161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.